Fifth Third Bancorp
ETON icon

Fifth Third Bancorp’s Eton Pharmaceutcials ETON Stock Holding History

Fifth Third Bancorp’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,190
Closed -$65K – 2696
2021
Q4 		$65K Buy
+15,190
New +$72.7K ﹤0.01% 1402

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's ETON Position: Q1 2022 in Review

Fifth Third Bancorp sold out of Eton Pharmaceutcials (ETON) in Q1 2022, closing a stake of 15,190 shares — an estimated $65K sold.

Fifth Third Bancorp first reported a position in ETON in Q4 2021 and held it in 1 quarter. The position peaked at $65K in Q4 2021. 31 funds tracked by Wall St. Rank hold ETON as of Q1 2022.

  • Fifth Third Bancorp reported no remaining Eton Pharmaceutcials position as of Q1 2022 after selling out during the quarter.
  • Fifth Third Bancorp sold 15,190 Eton Pharmaceutcials shares in Q1 2022, an estimated $65K.
  • Fifth Third Bancorp first reported a position in Eton Pharmaceutcials in Q4 2021 and held it in 1 quarter.
  • Fifth Third Bancorp's Eton Pharmaceutcials position peaked at $65K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2022.

Based on Fifth Third Bancorp's 13F filing for Q1 2022, filed 19 Apr 2022.